2633 completed, 474 unknown, 429 terminated, 234 withdrawn. 4034 Phase 2, 687 Phase 1, 486 Phase 3.
Follow RNA Virus Infections: new trials by email Literature Review of RNA Virus Infections trials Research Report on RNA Virus Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Reducing Arterial Inflammation Using Eplerenone and Statins in HIV Eplerenone, Placebo - HIV (Human Immunodeficiency Virus), Cardiovascular Diseases (CVD) | Phase 2 / Phase 3 | Not yet recruiting | Massachusetts General Hospital | 124 | 2027-03-01 | 2026-10-23 |
| Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers Ervebo, Inmazeb - Ebola Virus Disease | Phase 2 | Not yet recruiting | ANRS, Emerging Infectious Diseases | 132 | 2027-01-01 | 2026-01-22 |
| Evaluation of the Safety and Efficacy of XoGlo Pro, a Placental Mesenchymal Stem Cell-derived Extracellular Vesicles in Treating COVID-19 Symptoms IV infusion using an isolated, placental, mesenchymal stem cell derived EVs, Placebo IV administration - COVID-19 | Phase 1 / Phase 2 | Not yet recruiting | Kimera Labs Inc. | 64 | 2027-01-01 | 2026-06-24 |
| Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa VPM1002 Vaccine, BCG Vaccine, Placebo - Tuberculosis, HIV Infections | Phase 1 / Phase 2 | Withdrawn | International Maternal Pediatric Adolescent AIDS Clinical Trials Group | 2026-12-31 | 2026-08-17 | |
| Taurine Supplementation in Adolescents With Post-COVID Condition Taurine - Long COVID, Post COVID-19 Condition | Phase 1 / Phase 2 | Not yet recruiting | University of Alberta | 30 | 2026-12-30 | 2026-10-16 |
| DOR/ISL in Pediatric Participants With HIV-1, <18 Years of Age and ≥ 35 kg DOR/ISL - HIV-1, HIV Infection | Phase 2 | Not yet recruiting | Merck Sharp & Dohme LLC | 45 | 2026-12-23 | 2026-11-17 |
| Block-LC SGB Treatment Trial Bupivacaine-HCl, Lidocaine - COVID -19 | Phase 2 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 272 | 2026-12-09 | 2026-11-19 |
| CD19-B Cell Depletion in PAIS-ME/CFS Patients Inebilizumab, Placebo - Post-acute Infectious Syndrome (PAIS), Post-COVID 19 Condition (PCC or Long COVID) | Phase 2 | Not yet recruiting | Charite University, Berlin, Germany | 38 | 2026-12-01 | 2026-07-24 |
| Immunotherapy With Glatiramer Acetate in PLWHIV in Poor Immunological Responders on Antiretroviral Therapy - Study treatment arm group (Arm A): GLATIRAMER VIATRIS 40mg/ml - HIV - Human Immunodeficiency Virus | Phase 2 | Not yet recruiting | ANRS, Emerging Infectious Diseases | 36 | 2026-12-01 | 2026-10-01 |
| Psilocybin Therapy for Methamphetamine Use Disorder and HIV Psilocybin 5 mg, Psilocybin 25 mg, Motivational Support - Methamphetamine Use Disorder, Human Immunodeficiency Virus (HIV) | Phase 2 | Recruiting | Nicky Mehtani, MD, MPH | 30 | 2026-12-01 | 2026-11-09 |
| Baricitinib Curative Repression of HIV-1 Antiretroviral Therapy (ART), Baricitinib (LY3009104) 2 mg, Baricitinib (LY3009104) 4 mg - HIV Infection, HIV | Phase 2 | Not yet recruiting | Emory University | 35 | 2026-12-01 | 2026-11-13 |
| Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women With HIV in Kenya 5% 5-fluorouracil Topical Cream, Placebo Cream - HIV Infections, HPV Infection | Phase 2 | Not yet recruiting | UNC Lineberger Comprehensive Cancer Center | 140 | 2026-12-01 | 2026-11-17 |
| BPL-1357 Against H1N1 Influenza Virus Challenge BPL-1357 IM, BPL-1357 IN, Placebo IM - Influenza, Human | Phase 2 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 129 | 2026-11-24 | 2026-11-19 |
| A Clinical Study of Ixazomib to Reactivate HIV and Reduce HIV Reservoir Size Ixazomib 4 mg, Placebo - HIV (Human Immunodeficiency Virus) | Phase 2 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 45 | 2026-11-23 | 2026-11-12 |
| Phase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection. SYH2066, Placebo - Respiratory Syncytial Virus Infections | Phase 2 | Not yet recruiting | CSPC Ouyi Pharmaceutical Co., Ltd. | 80 | 2026-11-13 | 2026-10-20 |
| Rimonabant for Cognitive Impairment in People With Post-COVID-19 Syndrome Rimonabant, Placebo - Post-COVID-19 Syndrome | Phase 2 | Not yet recruiting | Sinfatin S.L | 80 | 2026-11-06 | 2026-11-12 |
| High-Dose Versus Standard-Dose Influenza Vaccine in Patients With Hematologic Malignancies Receiving B-Cell-Depleting Therapy High-dose inactivated influenza vaccine, Standard-dose inactivated influenza vaccine - Hematologic Malignancy, Influenza | Phase 2 | Recruiting | Sung-Han Kim | 60 | 2026-11-02 | 2026-11-09 |
| LM11A-31 Safety and Tolerability in Aging People Living With HIV and Neurocognitive Impairment LM11A-31, Placebo - HIV-ASSOCIATED NEUROCOGNITIVE DISORDER (HAND) | Phase 1 / Phase 2 | Not yet recruiting | University of North Carolina, Chapel Hill | 68 | 2026-11-01 | 2026-11-18 |
| A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB) Isoniazid, Rifampin, Pyrazinamide - Tuberculosis | Phase 2 | Not yet recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 900 | 2026-10-30 | 2026-08-19 |
| Evaluation of the Efficacy and Safety of 102D-6 in the Treatment of Acute Uncomplicated Influenza 20 mg 102D-6 dry suspension, 40 mg 102D-6 dry suspension, Placebo - Influenza, Human | Phase 2 / Phase 3 | Not yet recruiting | Capital Medical University | 570 | 2026-10-21 | 2026-10-26 |
Showing 20 of 4034. Sign in to see all of them.
COVID-19 (1393) · HIV Infections (919) · Influenza, Human (493) · Acquired Immunodeficiency Syndrome (418) · Hepatitis C (339) · Coronavirus Infections (274) · Hepatitis C, Chronic (227) · Virus Diseases (100) · Post-Acute COVID-19 Syndrome (95) · Respiratory Distress Syndrome (80) · Respiratory Syncytial Virus Infections (80) · Severe Acute Respiratory Syndrome (78) · Infections (76) · Pneumonia (74) · Dengue (63)
Infections (3958) · Virus Diseases (3934) · Respiratory Tract Diseases (2009) · Respiratory Tract Infections (1967) · Blood-Borne Infections (1619) · Communicable Diseases (1619) · Nidovirales Infections (1510) · Coronaviridae Infections (1509) · Lung Diseases (1486) · Pneumonia, Viral (1429) · Pneumonia (1397) · Coronavirus Infections (1241) · Immune System Diseases (1207) · Urogenital Diseases (1163)
Ribavirin (244) · Ritonavir (134) · peginterferon alfa-2a (115) · Influenza Vaccines (100) · Standard of Care (91) · Zidovudine (79) · Sodium Chloride (75) · Hydroxychloroquine (69) · Lamivudine (67) · Tenofovir (64) · Saline Solution (63) · Sofosbuvir (57) · Didanosine (49) · Lopinavir (49) · efavirenz (46)
National Institute of Allergy and Infectious Diseases (NIAID) (379) · GlaxoSmithKline (114) · Gilead Sciences (81) · Merck Sharp & Dohme LLC (74) · Sanofi Pasteur, a Sanofi Company (74) · ViiV Healthcare (41) · ANRS, Emerging Infectious Diseases (37) · Bristol-Myers Squibb (36) · Pfizer (31) · Hoffmann-La Roche (30) · Novartis Vaccines (29) · French National Agency for Research on AIDS and Viral Hepatitis (28) · U.S. Army Medical Research and Development Command (28) · Boehringer Ingelheim (27) · National Cancer Institute (NCI) (21)
United States (1775) · France (251) · Canada (230) · Spain (225) · Germany (217) · United Kingdom (211) · Puerto Rico (207) · South Africa (188) · Brazil (177) · China (162) · Italy (159) · Australia (132) · Belgium (125) · Thailand (123) · Mexico (114)
Mike Royal, MD (14) · Kiat Ruxrungtham, MD (8)
PMID 34473343, PMID 35713300, PMID 34013969, PMID 36734509, PMID 37162745, PMID 35244208, PMID 34658014, PMID 31986264, PMID 32031570, PMID 32171076, PMID 32109013, PMID 32142651, PMID 33502773, PMID 39903535, PMID 40190112, PMID 32192578, PMID 32788708, PMID 33044747, PMID 34895272, PMID 39756216, PMID 40099800, PMID 40592258, PMID 28193518, PMID 29515037, PMID 30012435, PMID 30664876, PMID 30923816, PMID 30977945, PMID 32112977, PMID 32205204, PMID 32251768, PMID 32738928, PMID 33306989, PMID 33617777, PMID 33754144, PMID 34817414, PMID 36700518, PMID 37489818, PMID 38077399, PMID 40342086, PMID 40655875, PMID 41720282, PMID 42253092, PMID 11756340, PMID 11960602, PMID 12086935, PMID 15141377, PMID 16308421, PMID 17941868, PMID 18832244
2014 (29), 2009 (23), 2015 (23), 2016 (19), 2008 (17), 2023 (17), 2019 (12), 2018 (11), 2017 (8), 2025 (8), U01CA121947 (6), UM1CA121947 (6), 2004 (5), U01AI068636 (5), 2005 (4)